Merck, Fosamax Plaintiffs Clash Over Discovery
The plaintiffs in multidistrict litigation against Merck & Co. Inc. over osteoporosis drug Fosamax argued in a Manhattan courtroom Monday that the scope of discovery should be expanded, but Merck warned...To view the full article, register now.
Already a subscriber? Click here to view full article